Syndromic Surveillance of Gastrointestinal Illness Using Pharmacy ...

2 downloads 245 Views 288KB Size Report
Objective: To ascertain if monitoring over-the-counter (OTC) drug sales could provide a ... comparing retrospective pharmacy OTC sales of anti-nauseants and ...
Syndromic Surveillance of Gastrointestinal Illness Using Pharmacy Over-the-Counter Sales A Retrospective Study of Waterborne Outbreaks in Saskatchewan and Ontario Victoria L. Edge, BSc, MSc1,2 Frank Pollari, DVM, PhD1 Gillian Lim, BSc, MSc1 Jeff Aramini, DVM, PhD1 Paul Sockett, PhD1 S. Wayne Martin, DVM, PhD2 Jeff Wilson, DVM, PhD1,2 Andrea Ellis, DVM, MSc1

ABSTRACT Objective: To ascertain if monitoring over-the-counter (OTC) drug sales could provide a timely syndromic surveillance method of detecting outbreaks of gastrointestinal illness. Method: This study evaluated the potential of a syndromic surveillance system by comparing retrospective pharmacy OTC sales of anti-nauseants and anti-diarrheals to emergency room visits and case numbers from two Canadian outbreaks related to water contamination by Cryptosporidium, and E.coli O157:H7 and Campylobacter. Results: Local sales trends of weekly aggregate OTC products were comparable to the outbreak epidemic curves. Statistical control tests on the sales data indicated the start of the outbreak periods. Conclusions: An automated monitoring tool based on spatial and temporal trend analyses of daily OTC sales would provide supplemental community health information for public health officials that is timelier than currently available laboratory-based surveillance systems.

La traduction du résumé se trouve à la fin de l’article. 1. Foodborne, Waterborne and Zoonotic Infections Division, Health Canada, Guelph, Ontario 2. Department of Population Medicine, University of Guelph Correspondence and reprint requests: Victoria L. Edge, Foodborne, Waterborne and Zoonotic Infections Division, Health Canada, 160 Research Lane, Unit 206, Guelph, ON N1G 5B2, Tel: 519826-2272, Fax: 519-826-2244, E-mail: [email protected] Acknowledgements: We thank the Walkerton Outbreak Investigation Team of the Grey Bruce Health Unit, Ontario; the Battlefords Outbreak Investigation Team of the North Battleford Health Unit, Saskatchewan; the South Bruce Grey Health Centre, Ontario; Dr. Rob Stirling; Mr. Ken Brown; Walkerton area pharmacists; Battlefords area pharmacists; Saskatchewan Ministry of Health; Ontario Ministry of Health and Long-term Care 446 REVUE CANADIENNE DE SANTÉ PUBLIQUE

A

primary aim of community health surveillance is to provide timely and accurate information on the health status of residents and to prompt public health action. In Canada, most notifiable infectious diseases, including enteric infections, currently are identified through laboratory confirmation. As a result, there is a significant period of time between when patients become ill, seek primary health care and the eventual notification of public health officials. If, for example, an infectious agent is introduced into community water supplies (whether unintentionally or intentionally), this lag time can impede detection of a disease outbreak and implementation of effective interventions to prevent further illnesses or deaths. In addition, several studies discuss the issue of the low proportion of cases that are actually captured throughout reporting chains,1-3 effectively providing health officials with data that underestimate community occurrences. By exploring potential sources of additional information for monitoring community health, syndromic surveillance (surveillance based on an aggregate of signs and symptoms) emerged as a prospective method to identify or verify communitywide increases in different disease syndromes (e.g., diarrheal illness). Several sources of community-level information can be used in this way, such as the monitoring of 911 calls, absenteeism in schools, nurse telehealth calls, emergency room visits and sales of over-thecounter (OTC) drugs.4,5 In this study, we investigated how pharmacy sales trends compared to both the frequency of emergency room visits and identified cases of gastrointestinal illness (GI), by reviewing retrospective data from two Canadian waterborne outbreaks with different disease onset patterns. The primary aim was to explore relationships between pharmacy OTC sales and the epidemic curves; one in the Battlefords area of Saskatchewan (spring of 2001), and the other in Walkerton, Ontario (spring of 2000). Two statistical aberration detection methods were used to assess how early the OTC sales data indicated a potential outbreak was occurring. METHODS Data collection – Battlefords, Saskatchewan An epidemiological investigation of the outbreak of Cryptosporidium infections VOLUME 95, NO. 6

PHARMACY SALES FOR SYNDROMIC SURVEILLANCE

TABLE I Data Sources Used for Analyses in This Study Type of Data

Battlefords, Saskatchewan Waterborne Outbreak: Cryptosporidium Infection

Walkerton, Ontario Waterborne Outbreak: E.coli O157:H7 and Campylobacter Infection

Pharmacy OTC Sales

Anti-diarrheals & Anti-nauseants • Aggregate unit sales* of 4 products, by week (Jan-May 2000 & 2001)

Anti-diarrheals & Anti-nauseants • Aggregate unit sales* of 12 products by week (Jan 1999-Dec 2000) of Walkerton pharmacy

Case-related Data

• Case-series data • Cross-sectional study

• Case-series data • Cross-sectional study

Emergency Room Visit Data

All patients diagnosed with acute GI illness (Feb-May 2001)

All patients diagnosed with acute GI illness/ vomiting/diarrhea (Mar-June 2000)

* Total weekly unit sales of OTC products classified by pharmacist as either anti-diarrheal or anti-nauseant.

NOVEMBER – DECEMBER 2004

140

120

Epidemic (confirmed & epi-linked cases by date of onset) andUnit weekly Epidemiccurve Curve (confirmed & epi-linked cases by date of onset) and Weekly Aggregate Sales of Over-the-Counter Anti-Nauseant and Anti-Diarrheal Products aggregate unit sales of over-the-counter anti-nauseant and anti-diarrheal products The Battlefords, Saskatchewan (January 20012001) - May 2001) The Battlefords, Saskatchewan (January 2001 - May Boil water advisory. (25th April)

Weekly OTC Sales

60

50

Total Cases (confirmed & epi-linked)

100

80 Start of outbreak period. (20th March)

60

30

Number of Cases

OTC Unit Sales

40

20 40 10

20

0

1Ja 5- n Ja 9- n J 13 an -J 17 an -J 21 an -J 25 an -J 29 an -J a 2- n Fe 6- b Fe 10 b -F 14 eb -F 18 eb -F 22 eb -F 26 eb -F e 2- b M a 6- r M 10 ar -M 14 ar -M 18 ar -M 22 ar -M 26 ar -M 30 ar -M a 3- r Ap 7- r Ap 11 r -A 15 pr -A 19 pr -A 23 pr -A 27 pr -A p 1- r M a 5- y M a 9- y M 13 ay -M 17 ay -M 21 ay -M 25 ay -M 29 ay -M ay

0

Date

Frequency of emergency room visits for acute GI and weekly aggregate unit sales of over-the-counter anti-nauseant and anti-diarrheal products The Battlefords, Saskatchewan (January 2001 - May 2001)

140

120

18 Boil water advisory. (25th April)

Weekly OTC Sales

Emergency Visits

16 14

100 12 80

Start of outbreak period. (20th March)

60

10 8 6

40 4 20

Number of ER Visits for Acute GI

b) b)

OTC Unit Sales

Data collection – Walkerton, Ontario Data from a descriptive case series and cross-sectional study,7 conducted to investigate a waterborne outbreak that occurred in Walkerton between May and June 2000, were used. In February 2002, six pharmacies in Walkerton and the surrounding area were asked to provide OTC sales data for the outbreak period. Logistically, only one pharmacy (in Walkerton) was able to supply electronic weekly aggregate unit sales relating to acute GI (anti-nauseants, antidiarrheals and rehydration products). These were provided for January 1, 1999 to December 31, 2000. In December 2002, the South Bruce Grey Health Centre in Walkerton provided ER visit

a)

a)

2

0

0

1Ja 5- n Ja n 9Ja 13 n -J a 17 n -J a 21 n -J a 25 n -J a 29 n -J a 2- n Fe 6- b F 10 eb -F 14 eb -F 18 eb -F 22 eb -F 26 eb -F e 2- b M a 6- r M 10 ar -M 14 ar -M 18 ar -M 22 ar -M 26 ar -M 30 ar -M a 3- r Ap 7- r Ap 11 r -A 15 pr -A 19 pr -A 23 pr -A 27 pr -A p 1- r M a 5- y M a 9- y M 13 ay -M 17 ay -M 21 ay -M 25 ay -M 29 ay -M ay

that affected individuals from both the City of North Battleford and the Town of Battleford (collectively known as ‘the Battlefords’) included a descriptive case series study, a randomized cross-sectional study, and an investigation of pharmacy sales of selected OTC products.6 The outbreak period lasted from March to May 2001. A subset of information collected for the outbreak investigation, described by Stirling et al.,6 is used in this study. Since each of the three pharmacies in the City of North Battleford had different sales inventory periods (either weekly or monthly), data from a pharmacy with weekly summaries of unit sales of four commonly used OTC products related to acute GI were chosen for this study (Table I). A unit sale was described as the sale of one item, regardless of volume (i.e., 100 ml vs. 500 ml) or quantity (i.e., 10 capsule package vs. 100 capsule package). Daily frequencies of Emergency Room (ER) visits of patients diagnosed with acute GI were obtained for February through May 2001.

Date

Figure 1.

A comparison of weekly aggregate unit sales of over-the-counter anti-diarrheals and anti-nauseants with the epidemic curve (a) and emergency room visits (North Battleford Hospital) related to gastrointestinal illness (b) from January to May 2001 in The Battlefords, Saskatchewan. The epidemic curve indicates the total number of isolate-confirmed cases and epidemiologically-linked cases by reported onset date.

CANADIAN JOURNAL OF PUBLIC HEALTH 447

PHARMACY SALES FOR SYNDROMIC SURVEILLANCE Epidemic Curve (confirmed & epi linked cases by onset date) and

80

Boil water advisory. (21stadvisory. May) Boil water

80 70

OTC sales Weekly OTC sales

70 60

OTC sales Weekly OTC sales Total Cases (confirmed & epi-linked) Total Cases (confirmed & epi-linked)

60

(21st May)

Start of outbreak Start ofperiod. outbreak (13th May) period.

160 140

140 120

120

(13th May)

50

100 Heavy rainfall. (8-12th HeavyMay) rainfall.

50 Unit Sales

160

40

100 80

(8-12th May)

40

Number of Cases

Epidemic curveEpidemic (confirmed & epi-linked cases by date ofdate) onset) weekly Weekly Aggregate Unit Sales of Over-the-Counter Anti-Nauseant and Anti-Diarrheal Products Curve (confirmed & epi-linked cases by onset and and Walkerton, Marchanti-nauseant 2000 - June 2000 Weeklyunit Aggregate of Ontario Over-the-Counter Anti-Nauseant and Anti-Diarrheal Productsproducts aggregate salesUnit ofSales over-the-counter and anti-diarrheal Walkerton, Ontario March 2000 - June 2000 Walkerton, Ontario (March 2000 - June 2000)

80

30

60

30

60

20

Number of Cases

a) a) a)

RESULTS

40

20

40

10

20

10

20

0

0

0

1M ar M 5-M ar a 5- 9 r M -M ar a 9- 1 3 r M -M a 13 1r ar -M 7a M 17 2r ar -M 1a M 21 2r ar -M 5a M 25 2r ar -M 9a M 29 r ar -M 2 ar -Ap 2- 6 r Ap -A r p 6- 10 r Ap -A 10 1r pr -A 4 p A 14 1r pr -A 8p A 18 2r pr -A 2p A 22 2r pr -A 6p A 26 3r pr -A 0 p A 30 r pr -A 4pr Ma 4- 8 y M -M ay a 8- 12 y M -M a 12 1y ay -M 6a M 16 2y ay -M 0a M 20 2y ay -M 4a M 24 2y ay -M 8a M 28 y ay -M 1 ay -Ju n 1- 5 Ju -J n un 5- 9 Ju -J n un 9- 1 3 Ju -J n u 13 1 n -J 7 un Ju 17 2 n -J 1u Ju 21 n2 n -J 5 un Ju 25 2 n -J 9u Ju 29 n n -J un

0

1-

Date

Date

Frequency of Emergency Room Visits for Acute GI and Weekly Aggregate Unit Sales of Over-the-Counter Anti-Diarrheal andacute Anti-Nauseant Frequency of Emergencyroom Room Visits Acute GI and Aggregateaggregate Unit Sales ofunit sales of b) Frequency of emergency visitsforfor GIWeekly andProducts weekly Walkerton, Ontario 2000Anti-Nauseant - June 2000 Products Anti-Diarrheal and b) over-the-counterOver-the-Counter anti-nauseant andMarch anti-diarrheal products Walkerton, Ontario March 2000 - June 2000 b) Walkerton, Ontario (March 2000 - June 2000) 80 Boil water advisory. Boil water (21stadvisory. May)

70

OTC sales Weekly OTC sales OTC sales Emergency Room Visits

60

60 50

Units Sold

50

Emergency Room Visits

(21st May) Start of outbreak Start ofperiod outbreak (13th May) period

80 70

70 60

60 50

50

(13th May)

40

40

Number of ER Visits for Acute GI

80 70

40

40 30

30

30

30 20

20

20

20

Number of ER Visits for Acute GI

80

10

10

10

10 0

0 1M a 1- 5 r M -M ar a 5- 9 r M -M ar a 9- 13 r M -M a 13 1r ar -M 7a M 17 2r ar -M 1a M 21 2r ar -M 5a M 25 2r ar -M 9ar Ma 29 r -M 2 ar -Ap 2- 6 r Ap -A r p 6- 10 r Ap -A 10 1r pr -A 4p A 14 1r pr -A 8p A 18 2r pr -A 2p A 22 2r pr -A 6pr A p 26 3 r -A 0p A 30 r pr -A 4pr M a 4- 8 y M -M ay a y 8- 1 M 2a M 12 1y ay -M 6a M 16 2y ay -M 0a M 20 2y ay -M 4a M 24 2y ay -M 8a M 28 y ay -M 1 ay -Ju 1- 5 n Ju -J n u 5- 9 n Ju -J n u 9- 13 n Ju -J n 13 1 un -J 7un J 17 2 un -J 1u J 21 n2 un -J 5un J 25 2 un -J 9u J 29 n un -J un

0

0

Date

Date

Figure 2.

A comparison of weekly aggregate unit sales of over-the-counter anti-diarrheals and anti-nauseants with the epidemic curve (a) and emergency room visits (Walkerton Hospital) related to gastrointestinal illness (b) from March through June 2000 in Walkerton, Ontario. The epidemic curve indicates the total number of isolate-confirmed cases and epidemiologically-linked cases by reported onset date. Note that the first confirmed isolate of E.coli O157:H7 was reported to the local Health Unit on May 20, 2000.

information as daily aggregate counts of patients diagnosed with diarrhea, vomiting or acute gastrointestinal illness for the period of March through June 2000. A summary of data used in this study is given in Table I.

aggregate unit sales of OTC anti-diarrheals and anti-nauseants, plotted by the end of the sales week date, were produced for each pharmacy. The daily frequency of ER visits (by visit date) related to acute GI was also plotted for the two outbreaks.

Comparing the epidemic curve, unit sales of OTC products and emergency room visits Epidemic curves for both the Battlefords and the Walkerton outbreak were based on case numbers by onset date derived from the case series investigations. Weekly

CUSUM and moving average in detecting aberrations Two statistical control methods were applied to 2 years of aggregate weekly sales data (January 1999 through December 2000) from the Walkerton pharmacy, in order to detect aberrations in sales events over time.

448 REVUE CANADIENNE DE SANTÉ PUBLIQUE

The Cumulative Sum (CUSUM), which requires historical information, and simple Moving Average (MA) analyses were run using the SAS© statistical package.8 The threshold for the CUSUM was set at h=2; for the Moving Average (span of 2), three standard deviations from the mean defined the limits. Details on these algorithms may be obtained elsewhere.9-11

The Battlefords Figure 1a shows the epidemic curve (number of cases plotted by onset date) and combined weekly aggregate unit sales of OTC anti-diarrheals and anti-nauseants in the weeks up to and including the outbreak period. The plot includes cases that occurred prior to (n=119), and during the outbreak period (n=1039). In total, 10.6% of outbreak-related cases were reported (laboratory-confirmed) to the Public Health Unit; the remaining epidemiologically linked cases (not laboratoryconfirmed) were identified retrospectively through investigative surveys. A dramatic increase in OTC sales is shown during the outbreak period. OTC sales data were also plotted against the frequency of ER visits of patients diagnosed with acute GI (Figure 1b). The increasing trend evidenced at the start of the outbreak period in both the OTC sales and epidemic curve is not obvious in the more variable ER visits trend line. Walkerton Figure 2a compares weekly aggregate OTC unit sales of anti-diarrheals and antinauseants with the epidemic curve, which included all cases that were epidemiologically linked to the outbreak. The sharp drop in unit sales after the week ending the 26th of May was a result of pharmacists halting purchases of products related to GI on the 20 th of May, except upon consultation with a pharmacist. A comparison of OTC sales with the frequency of patients visiting the Walkerton hospital ER, and diagnosed with GI, is found in Figure 2b. Sales were seen to rise sharply at the same time as the epidemic curve, but ER visits did not show an obvious increase until well after the large spikes in both the OTC sales trend and the epidemic curve. VOLUME 95, NO. 6

PHARMACY SALES FOR SYNDROMIC SURVEILLANCE

DISCUSSION In Canada, there is currently no organized system that uses syndromic data, such as pharmacy OTC sales, for community health surveillance. Our study supports the hypothesis that monitoring OTC sales activities of certain drugs gives an indication of GI-related events in the community, and thus can provide vital information for public health, in the form of systematic observation of trends. This is particularly important in situations where infected NOVEMBER – DECEMBER 2004

Anti Diarrheal and Anti Nauseant Products A Walke rton, Ontario Pharmacy (January 1999 - Fe bruary 2001) 80 lower control lim it (-3sd) 70

Start of outbreak period (13th May)

m oving avg overall m ean upper control lim it (+3sd)

MA of unit sales

60

MA climbing sharply for sales week ending May 19th. Exceeds 3 std deviations week ending May 26th.

Sales weeks ending Dec 24th and 31st. MA exceeds 3 std deviations.

50

44.43 40

30

26.44 20

10

8.45

1999

Figure 3.

28 -Ju l 27 -A ug 26 -S ep 26 -O ct 25 -N ov 25 -D ec 24 -Ja n 23 -F eb 25 -M ar 24 -A pr

1-D ec 31 -D ec 30 -Ja n 29 -F eb 30 -M ar 29 -A pr 29 -M ay 28 -Ju n

2-O ct

1-N ov

2-S ep

4-J ul 3-A ug

4-J un

6-M ar

5-A pr 5-M ay

5-J an

4-F eb

6-D ec

0

2000

Date (week ending)

2001

Moving Average (MA) chart (span of 2), using two years of weekly aggregate sales (1999-2000) of OTC anti-nauseant and anti-diarrheal products from a Walkerton pharmacy. Aberrant sales are indicated when the MA exceeds 3 standard deviations. A Walkerton, Ontario Pharmacy (January 1999- February 2000)

7

6

( h=2; mean=26.04; std dev=8.82 ) Sales w eeks ending Dec 24th and 31st. CUSUM exceeds threshold .

CUSUM value

5

Sales w eek ending May 19th CUSUM exhibiting sharply rising slope. Exceeds threshold for w eek ending May 26th.

Start of outbreak period (13th May)

4

3

CUSUM threshold 2

1

1999

Figure 4.

W eek Ending

3Ju l 28 -J u 22 l -A ug 16 -S ep 11 -O ct 5N ov 30 -N ov

8Ju n

-M ar 19 -A pr 14 -M ay

-F eb

25

29

4Fe b

0 31 -D ec 25 -J an 19 -F eb 16 -M ar 10 -A pr 5M ay 30 -M ay 24 -J un 19 -J u 13 l -A ug 7Se p 2O ct 27 -O ct 21 -N ov 16 -D ec 10 -J an

Statistical algorithms applied to OTC sales data for aberration detection Moving Average (MA) and CUSUM plots using the weekly aggregate sales data of GIrelated products from the Walkerton pharmacy are shown in Figures 3 and 4 respectively. Points are plotted by the end of the weekly sales period (Saturday through Friday) dates. Both statistical control methods detected significantly high sales for the same two periods over these 24 months. In December of 1999, the CUSUM trend line crossed the threshold for two consecutive weeks (ending the 24th and the 31st). The MA also showed high sales for these two periods, with the trend line approaching the upper limit the week ending the 24th, and surpassing it the week ending the 31st. Total unit sales for these two weeks were 53 and 37 respectively. The next period of significantly increased sales was during the May 2000 outbreak. Symptom onset dates were reported as starting around the 13 th of May; numbers of cases quickly escalated in the days following. Trend lines from both the MA and the CUSUM climbed for the sales week ending the 19th, and then spiked sharply, greatly exceeding the upper boundary lines for the sales week ending the 26th. Of note is that since GI-related product sales were halted by the afternoon of the 20th and the store was closed on the 21st and 22nd, the major spike reflected predominantly sales from the morning of the 20th. Total sales for the weeks ending the 19 th and the 26 th were 49 and 74 units, respectively. In comparison, average weekly sales in the four weeks prior to the outbreak were 23 units. Excluding the four periods of high sales, weekly aggregate sales over the two years of data ranged from 11 to 45 units.

2000

Cumulative Sum (CUSUM) technique using a Walkerton pharmacy’s sales of OTC products relating to gastrointestinal illness (weekly aggregate counts for 1999-2000) The system is seen to be ‘out of control’ when the curve crosses the dashed line (CUSUM threshold).

individuals have symptoms prompting selfmedication, rather than going to a private practice or emergency room physician, as was evidenced in the Battlefords outbreak trends. Under these circumstances, OTC sales trends would provide a more sensitive, timely and geographically specific detection tool than is available through monitoring ER visits or the slower laboratory-based surveillance. It is important to remember that though cases are plotted by onset date, public health officials would not receive notification of these reportable

isolate occurrences until at least several days later. Though sales patterns of OTC products showed a definitive increase at the same time as onset dates of outbreakrelated cases in both outbreaks discussed here, there is a key difference between the two. The speed and magnitude of the waterborne outbreak related to contamination by E.coli O157:H7 and Campylobacter in Walkerton was reflected in the correspondingly large and rapid increase in sales of related OTC products in the same week. In the Battlefords, the more proCANADIAN JOURNAL OF PUBLIC HEALTH 449

PHARMACY SALES FOR SYNDROMIC SURVEILLANCE

longed period of elevated OTC drug sales reflected the almost 90% of unreported cases during the outbreak, many of whom were self-medicating in response to the less severe symptoms of Cryptosporidium infection. A relationship between pharmacy OTC sales data and epidemic curves (related to GI) has been documented for several waterborne outbreaks.12-16 The statistical control tests used in this study simply demonstrated the utility of aberration detection methodology. However, adaptations to these and more sophisticated algorithms, such as the Early Aberration Reporting System (EARS),17,18 time series methods, neural networks and spatial modelling, will have to be developed to adjust for a number of factors contributing to the general noisiness of these data, such as seasonal effects, promotional sales, pharmacy attributes, and type of population served. A limitation of this study was sales data availability, emphasizing the need to determine the required number of representative sites for an area necessary for describing different sales patterns aberrations (i.e., increased sales in three area pharmacies versus one pharmacy with increased sales for three days). Georeferencing these data will allow for patterns of disease occurrence to be described through a number of spatio-temporal analytical techniques, which would be useful for public health prevention and intervention planning. This study utilized retrospectively collected sales information to illustrate the usefulness of these data for real-time syndromic surveillance. To implement such a system at the community, provincial or national level will necessarily require a timely and consistent transfer and analysis of information to adequately monitor the target populations. Past attempts at using sales data supplied by phone or fax failed mainly due to limitations of time and personnel,19 so the success of such a system will rely on automating collection, analysis and dissemination of results to the appropriate health officials in a way which is useful to them. Major Canadian retailers have sophisticated, centralized database reg-

450 REVUE CANADIENNE DE SANTÉ PUBLIQUE

istries for electronic daily and historical stock keeping, so the feasibility of an automated surveillance system should be explored at this time. In conclusion, syndrome-based monitoring of OTC sales offers a simple and effective tool to enhance the ability of public health officials to detect trends and aberrations in community health, give a sense of the geographical area affected in outbreak situations, and provide historical patterns that would aid in planning preparedness and targeted interventions. REFERENCES 1. Hoogenboom-Verdegaal AMM, De Jong JC, During M, Hoogenveen R, Hoekstra JA. Community-based study of the incidence of gastrointestinal diseases in the Netherlands. Epidemiol Infect 1994;112:481-87. 2. Wheeler JG, Sethi D, Cowden JM, Wall PG, Rodrigues LC, Tompkins DS, et al. Study of infectious intestinal disease in England: Rates in the community, presenting to general practice, and reported to national surveillance. Br Med J 1999;318:1046-50. 3. Sethi D, Wheeler J, Rodrigues LC, Fox S, Roderick PJ. Investigation of underascertainment in epidemiological studies based in general practice. Int J Epidemiol 1999;28(1):10612. 4. Lewis MD, Pavlin JA, Mansfield JL, O’Brien S, Boomsma LG, Elbert Y, Kelley PW. Disease outbreak detection system using syndromic data in the Greater Washington DC area. Am J Prev Med 2002;23(3):180-86. 5. Lazarus R, Kleinman KP, Dashevsky I, DeMaria A, Platt R. Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): The example of lower respiratory infection. BMC Pub Health 2001;1(1):9. 6. Stirling R, Aramini J, Ellis A, Lim G, Meyers R, Fleury M, Werker D. North Battleford, Saskatchewan Spring 2001 Waterborne Cryptosporidiosis Outbreak. Health Canada

7.

8. 9. 10. 11. 12. 13.

14. 15.

16.

17.

18.

19.

Report, 2001. (http://www.health.gov.sk.ca/ info_center_pub_health_can_epi_report_NB.pdf) Bruce Grey-Owen Sound Health Unit and M. McQuigge. The Investigative Report on the Walkerton Outbreak of Waterborne Gastroenteritis, May-June 2000. SAS Institute Inc. SAS/STAT User’s Guide, Version 8, Cary, NC: SAS Institute, 1999. O’Brien SJ, Christie P. Do CuSums have a role in routine communicable disease surveillance? Pub Health 1997;111:255-58. Montgomery DC. Introduction to Statistical Quality Control. New York, NY: John Wiley and Sons, 1985. Tillet HE, Spencer I. Influenza surveillance in England and Wales using routine statistics. J Hyg 1982;88:83-94. Frost F, Craun GF, Calderon R. Waterborne disease surveillance. J Am Water Works Assoc 1996;September:66-78. Melnychuk D, Moride Y, Abenhaim L. Monitoring of drug utilization in public health surveillance activities: A conceptual framework. Can J Public Health 1993;84(1):45-49. Padiglione A, Fairley CK. Early detection of outbreaks of waterborne gastroenteritis. Water 1998; November:11-15. Rodman JS, Frost F, Davis-Burchat L, Fraser D, Langer J, Jakubowkski W. Pharmaceutical sales – A method of disease surveillance? Environ Health 1997;Nov:8-14. Proctor ME, Blair KA, Davis JP. Surveillance data for waterborne illness detection: An assessment following a massive waterborne outbreak of Cryptosporidium infection. Epidemiol Infect 1998;120:43-54. Hutwagner LC, Maloney EK, Bean NH, Slutsker L, Martin SM. Using laboratory-based surveillance data for prevention: An algorithm for detecting Salmonella outbreaks. Emerg Infect Dis 1997;3(3):395-400. Hutwagner L, Thompson W, Seeman GM, Treadwell T. The bioterrorism preparedness and response early aberration reporting system (EARS). J Urban Health 2003;80(2,suppl 1):i89i96. Talbot T, Emde K, Gammie L, Mainiero J, Gelfreich E, Barry A, et al. Guidance Manual on Waterborne Gastrointestinal Disease Outbreak Detection. Amer Water Works Assoc 2001;90871.

Received: October 22, 2003 Accepted: June 25, 2004

RÉSUMÉ Objectif : Vérifier si la surveillance des ventes de médicaments en vente libre pourrait être une méthode de surveillance syndromique opportune en vue de détecter les éclosions de maladies gastro-intestinales. Méthode : Nous avons évalué les possibilités d’un système de surveillance syndromique en comparant les ventes rétrospectives d’antinauséeux et d’antidiarrhéiques vendus librement en pharmacie aux visites en salles d’urgence et au nombre de cas associés à deux éclosions au Canada liées à la contamination de l’eau par Cryptosporidium, et par E.coli O157:H7 et Campylobacter. Résultats : Les tendances des ventes locales hebdomadaires de produits en vente libre suivaient les courbes des flambées épidémiques. Des contrôles statistiques des chiffres de vente ont indiqué le début des périodes d’éclosion. Conclusion : Un outil de surveillance automatique basé sur l’analyse des tendances spatiales et temporelles des ventes quotidiennes de médicaments en vente libre fournirait aux agents de santé publique des renseignements supplémentaires sur la santé communautaire plus à jour que les systèmes de surveillance actuellement utilisés par les laboratoires.

VOLUME 95, NO. 6